HOME >> BIOLOGY >> NEWS
Fauci To Present New Insights Into HIV Latency At 12th World AIDS Conference

During the past year, scientists have shown that HIV persists in a latent form within a relatively small number of resting CD4+ T cells, even in patients who have received prolonged combination antiretroviral therapy and have no readily detectable virus in their blood. Latently infected CD4+ T cells are potential sources of new viral replication if a patient stops therapy, and pose a formidable obstacle to the goal of eradicating HIV from a person's body, particularly if drug resistance develops.

New data show that latent pools of infected cells are established very early in the course of HIV infection, even if a patient is treated expeditiously with highly active antiretroviral therapy ("HAART" - generally a three- or four-drug combination that includes a protease inhibitor). Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID) and chief of the NIAID Laboratory of Immunoregulation (LIR), will present these and other new findings at the 12th World AIDS Conference in Geneva, Switzerland.

"We have shown that initiating HAART as soon as 10 days after the onset of the symptoms of acute HIV infection does not prevent the formation of a latent reservoir of virus," says Dr. Fauci. "By the time high levels of HIV are detectable in the blood, the virus probably has spread to the lymphoid organs and established a pool of latently infected cells.

"Our group and others are pursuing studies to identify and treat people recently exposed to HIV, before the burst of virus replication, which occurs in most patients soon after infection. Such studies will help determine whether it will be possible to prevent the early establishment of latent pools of HIV."

In Geneva, Dr. Fauci also will discuss the potential for diminishing latent pools of HIV - the possibility of "flushing out" the virus (at least in the test tube) - by stimulating latently infected CD4+ T cells with antibodies to the CD3 molecule on the cell
'"/>

Contact: Greg Folkers
gfolkers@nih.gov
(301) 496-2263
NIH/National Institute of Allergy and Infectious Diseases
30-Jun-1998


Page: 1 2 3

Related biology news :

1. Fauci: New Findings Help Explain "Rebound" Of HIV In Patients Who Discontinue Triple-Drug Therapy
2. Wiley publishes Welcome to the Genome: A Users Guide to the Genetic Past, Present, and Future
3. Presentation of Dr. Ingo Potrykus July 21 in Providence
4. Renowned Prostate Cancer Experts Present Latest Findings At UCSF Cancer Center Symposium
5. Echinacea Symposium Presents New Research On Chernobyl Victims
6. Cedars-Sinai Medical Center Physicians And Scientists Present Findings At Annual Meeting Of The Pediatric Academic Societies
7. Virginia Tech Research Group Presents Improved Dental Materials
8. Nations Leading Biomedical Researchers Present Breakthroughs in Liver Disease
9. USGS To Present Diverse Research At ESA Annual Meeting
10. Chern Memorial Award Presented To Wistar Institute Postdoctoral Fellow
11. Neurons Control Brain Immunity: Neurotrophins As Regulators Of Antigen-Presentation In Microglial Cells

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/20/2016)... 2016   Valencell , the leading innovator ... STMicroelectronics (NYSE: STM), a global semiconductor leader serving ... today the launch of a new, highly accurate ... includes ST,s compact SensorTile turnkey multi-sensor ... sensor system. Together, SensorTile and Benchmark deliver the ...
(Date:12/16/2016)... --  IdentyTechSolutions America LLC , a leading provider ... a cutting-edge manufacturer of software and hardware security ... integrated solutions that comprise IDT biometric readers and ... IdentyTech,s customers with combined physical identification and anti-tailgating ... theft. "We are proud to use ...
(Date:12/16/2016)... NEW YORK , Dec. 16, 2016 The global ... reach USD 12.14 billion by 2021 from USD 5.31 billion in ... ... market is mainly driven by technological advancements in medical devices, launch ... devices, rising preference for wireless connectivity among healthcare providers, and increasing ...
Breaking Biology News(10 mins):
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... Researchers from a new study ... not fall low enough after prostate cancer treatment, this indicates there is still remaining prostate ... of mortality. , “ The PSA test has always been an indicator of whether a ...
(Date:1/18/2017)... ... January 18, 2017 , ... uBiome, the leading ... by its Science Editor, Dr. Elisabeth Bik, in the December 2016 issue of ... joined uBiome in October 2016 from her previous position at Stanford University School ...
(Date:1/18/2017)... , Jan. 18, 2017  HUYA Bioscience International, (HUYA), ... China,s pharmaceutical innovations, announced today a ... Innovation and Investment Company (referred to as CAS Innovation). ... innovations discovered by leading scientists at CAS to meet ... HUYA is the first company to have recognized ...
(Date:1/18/2017)... Jan. 18, 2017  Market Research Future published a half-cooked research ... expected to grow at a CAGR of 12% during the period ... ... to the abnormal cell division without any control. These abnormal cells ... them. These cancer cells can spread to other parts of the ...
Breaking Biology Technology:
Cached News: